Sales decline 52.98% to Rs 377.20 crore
Net profit of Natco Pharma declined 67.84% to Rs 65.10 crore in the quarter ended September 2021 as against Rs 202.40 crore during the previous quarter ended September 2020. Sales declined 52.98% to Rs 377.20 crore in the quarter ended September 2021 as against Rs 802.20 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales377.20802.20 -53 OPM %18.6934.46 -PBDT104.50299.40 -65 PBT69.80270.70 -74 NP65.10202.40 -68Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
